Biocon Ltd Fact Sheet, Biocon Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Fact Sheet    (BICN)


One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

Here is the latest financial fact sheet of Biocon Ltd. For more details, see the Biocon Ltd quarterly results and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 333.6
Mkt Cap Rs m 200,130
Vol '000 269.4
P/E X 29.0
P/CF X 13.8
EPS (TTM) Rs 11.5
% ch % 1.9
No. of shares m 600.00
% ch week % 14.7
% ch 1-mth % 10.9
% ch 12-mth % 7.7
52 week H/L Rs 345.0/211.3
(As on Apr 9, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs5544961,1621,188707 
Low Rs407397483305554 
Sales per share (Unadj.) Rs154.5167.4194.668.791.9 
Earnings per share (Unadj.) Rs24.930.534.47.616.7 
Diluted earnings per shareRs8.310.211.57.616.7 
Cash flow per share (Unadj.) Rs35.942.948.314.024.2 
Dividends per share (Unadj.) Rs5.005.001.001.001.00 
Adj. dividends per shareRs1.671.670.331.001.00 
Dividend yield (eoy) %1.01.10.10.10.2 
Book value per share (Unadj.) Rs163.1201.7241.986.3101.6 
Adj. book value per shareRs54.467.280.686.3101.6 
Shares outstanding (eoy) m200.00200.00200.00600.00600.00 
Bonus/Rights/Conversions  ---IS- 
Price / Sales ratio x3.12.74.210.96.9 
Avg P/E ratio x19.314.623.998.937.7 
P/CF ratio (eoy) x13.410.417.053.426.1 
Price / Book Value ratio x2.92.23.48.66.2 
Dividend payout %20.116.42.913.26.0 
Avg Mkt Cap Rs m96,08089,220164,440447,900378,330 
No. of employees `0007.54.49.26.16.1 
Total wages/salary Rs m5,3346,1017,4709,31111,653 
Avg. sales/employee Rs Th4,119.77,581.94,213.96,705.88,994.3 
Avg. wages/employee Rs Th711.21,381.9809.01,514.21,900.7 
Avg. net profit/employee Rs Th663.21,379.6745.2736.91,635.3 
BIOCON  INCOME DATA
Net Sales Rs m30,89833,47438,91141,23455,144 
Other income Rs m5317921,5712,0621,444 
Total revenues Rs m31,42934,26640,48243,29656,588 
Gross profit Rs m6,9587,6789,7958,29115,883 
Depreciation Rs m2,2102,4872,7723,8514,478 
Interest Rs m89293260615709 
Profit before tax Rs m5,1905,6908,3345,88712,140 
Minority Interest Rs m-3102171632139 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m1,0511,606000 
Tax Rs m9571,4221,6161,5692,123 
Profit after tax Rs m4,9746,0916,8814,53110,026 
Gross profit margin %22.522.925.220.128.8 
Effective tax rate %18.425.019.426.717.5 
Net profit margin %16.118.217.711.018.2 
BIOCON  BALANCE SHEET DATA
Current assets Rs m24,75039,70940,47741,48648,228 
Current liabilities Rs m15,97416,65716,78321,41330,376 
Net working cap to sales %28.468.960.948.732.4 
Current ratio x1.52.42.41.91.6 
Inventory Days Days5659606468 
Debtors Days Days8178839486 
Net fixed assets Rs m34,16940,14645,07350,66164,130 
Share capital Rs m1,0001,0001,0003,0003,000 
"Free" reserves Rs m31,62239,33847,37748,80857,980 
Net worth Rs m32,62240,33848,37751,80860,980 
Long term debt Rs m7,67120,72421,08218,08315,766 
Total assets Rs m63,31984,58193,94299,897121,924 
Interest coverage x59.320.433.110.618.1 
Debt to equity ratio x0.20.50.40.30.3 
Sales to assets ratio x0.50.40.40.40.5 
Return on assets %8.07.57.65.28.8 
Return on equity %15.215.114.28.716.4 
Return on capital %14.912.812.69.616.8 
Exports to sales %33.532.033.429.228.1 
Imports to sales %19.721.220.317.818.9 
Exports (fob) Rs m10,33910,71712,98812,05815,506 
Imports (cif) Rs m6,1027,1057,8997,34810,399 
Fx inflow Rs m10,99311,78912,98812,05815,506 
Fx outflow Rs m7,3718,4457,8997,34810,399 
Net fx Rs m3,6223,3445,0894,7105,107 
BIOCON  CASH FLOW
From Operations Rs m 2,107 3,706 6,400 6,621 11,546 
From Investments Rs m -5,087 -11,417 -4,985 -6,840 -7,138 
From Financial Activity Rs m 1,862 10,676 -1,775 -2,397 -2,417 
Net Cashflow Rs m -1,118 3,000 -473 -2,612 2,103 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   ELDER PHARMA  CIPLA  WYETH LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare BIOCON With:   ELDER PHARMA  CIPLA  WYETH LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark(Closing)

Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Views on news

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now (The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

How to Identify a Market Rebound (Fast Profits Daily)

Mar 27, 2020

This very useful indicator can spot a market bottom.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

BIOCON - ALEMBIC PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS